4/18
07:45 am
evo
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
Low
Report
Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments
4/18
07:39 am
evo
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS [Yahoo! Finance]
Low
Report
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS [Yahoo! Finance]
4/18
07:27 am
evo
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
Low
Report
EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS
4/17
09:15 am
evo
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
Low
Report
Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024
4/17
01:50 am
evo
Evotec welcomes Aurélie Dalbiez as Chief People Officer
Low
Report
Evotec welcomes Aurélie Dalbiez as Chief People Officer
4/12
08:01 am
evo
Evotec SE (NASDAQ: EVO) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.
Medium
Report
Evotec SE (NASDAQ: EVO) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.
3/18
10:12 am
evo
Quotient Sciences Strengthens Its Top Team with Three New Appointments [Yahoo! Finance]
Neutral
Report
Quotient Sciences Strengthens Its Top Team with Three New Appointments [Yahoo! Finance]
3/6
02:02 am
evo
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic [Yahoo! Finance]
Low
Report
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic [Yahoo! Finance]
3/6
01:50 am
evo
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
Low
Report
Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic
2/21
08:44 am
evo
Induced Pluripotent Stem Cells Market projected to reach USD 4.4 Billion by 2030, growing at a CAGR of 9.2% during the forecast period of 2023-2030 - claims by MarketDigits in its recent study [Yahoo! Finance]
Low
Report
Induced Pluripotent Stem Cells Market projected to reach USD 4.4 Billion by 2030, growing at a CAGR of 9.2% during the forecast period of 2023-2030 - claims by MarketDigits in its recent study [Yahoo! Finance]
2/7
02:12 am
evo
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV [Yahoo! Finance]
Low
Report
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV [Yahoo! Finance]
2/7
02:00 am
evo
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
Low
Report
Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV
1/22
02:13 am
evo
Evotec SE: Invitation to Conference Call [Yahoo! Finance]
Medium
Report
Evotec SE: Invitation to Conference Call [Yahoo! Finance]
1/22
02:00 am
evo
Evotec SE: Invitation to Conference Call
Medium
Report
Evotec SE: Invitation to Conference Call